ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
FDA Cleared, CE Mark, Health Canada Licensed
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Recent News
October 30, 2019
iCAD Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2019
October 24, 2019
iCAD to Report Third Quarter 2019 Financial Results on Wednesday, October 30
October 07, 2019
ProFound AI™ Platform Featured at Journées Francophones de Radiologie Congress in Paris
October 1, 2019
iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest
September 16, 2019
iCAD Exhibiting New Updates and Enhanced Xoft Platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer
» View All News »
CONNECT
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
